Interpopulation variation in HIV testing promptness may introduce bias in HIV incidence estimates using the serologic testing algorithm for recent HIV seroconversion

Sexually Transmitted Infections

Volumn 86, Issue 4, 2010, Pages 254-257

  White, Edward ^a   Goldbaum, Gary ^b   Goodreau, Steven ^b   Lumley, Thomas ^b   Hawes, Stephen E ^b  

^a YALE UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADULT; ALGORITHM; ANTIBODY DETECTION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROCONVERSION; SEROLOGY; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; HIV INFECTIONS; HIV SEROPOSITIVITY; IMMUNOLOGY; MIDDLE AGED; MULTICENTER STUDY; STATISTICAL BIAS; UNITED STATES; YOUNG ADULT;

ADULT; ALGORITHMS; BIAS (EPIDEMIOLOGY); ENZYME-LINKED IMMUNOSORBENT ASSAY; HIV ANTIBODIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; INCIDENCE; MIDDLE AGED; WASHINGTON; YOUNG ADULT;

EID: 77956014552     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2009.037291     Document Type: Article

References (19)

1. Weinstock H, Sweeney S, Satten GA, et al. HIV incidence and risk factors among patients repeatedly tested for HIV attending sexually transmitted disease clinics in the United States, 1991 to 1996. J Acquir Immune Defic Syndr Hum Retro 1998;19:506-12.
2. Catania JA, Coates TJ, Stall R, et al. Changes in condom use among homosexual men in San Francisco. Health Psychol 1991;10:190-9.
3. McFarland W, Kellogg TA, Dilley J, et al. Estimation of human immunodeficiency virus (HIV) incidence among repeat anonymous testers in San Francisco. Am J Epidemiol 1997;146:662-4.
4. Karon JM, Fleming PL, Steketee RW, et al. HIV in the United States at the turn of the century: an epidemic in transition. Am J Public Health 2001;91:1060-8.
5. Karon JM, Khare M, Rosenberg PS. The current status of methods for estimating the prevalence of human immunodeficiency virus in the United States of America. Stat Med 1998;17:127-42. (Pubitemid 28043587)
6. Centers for Disease Control and Prevention (CDC). HIV prevalence estimates-United States, 2006. MMWR Morb Mortal Wkly Rep 2008;57:1073-6.
7. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998;280:42-8.
8. Burchell AN, Calzavara L, Ramuscak N, et al. Symptomatic primary HIV infection or risk experiences? Circumstances surrounding HIV testing and diagnosis among recent seroconverters. Int J STD AIDS 2003;14:601-8. (Pubitemid 37072177)
9. Wenger NS, Kusseling FS, Beck K, et al. When patients first suspect and find out they are infected with the human immunodeficiency virus: implications for prevention. AIDS Care 1994;6:399-405. (Pubitemid 24314373)
10. Remis RS, Palmer RW. Testing bias in calculating HIV incidence from the serologic testing algorithm for recent HIV seroconversion. AIDS 2009;23:493-503.
11. Centers for Disease Control and Prevention. Protocol: human immunodeficiency virus type 1 low sensitivity enzyme immunoassay. Atlanta: Modified Abbott 3A11, 1998.
12. Kitayaporn D, Uneklabh C, Weniger BG, et al. HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand. AIDS 1994;8:1443-50. (Pubitemid 24296802)
13. Satten GA, Janssen R, Busch MP, et al. Validating marker-based incidence estimates in repeatedly screened populations. Biometrics 1999;55:1224-7.
14. Kellogg TA, Loeb L, Dilley J, et al. Comparison of three methods to measure HIV incidence among persons seeking voluntary, anonymous counseling and testing. J Acquir Immune Defic Syndr 2005;39:112-20. (Pubitemid 40617026)
15. Nash D, Bennani Y, Ramaswamy C, et al. Estimates of HIV incidence among persons testing for HIV using the sensitive/less sensitive enzyme immunoassay. New York City, 2001. J Acquir Immune Defic Syndr 2005;39:102-11. (Pubitemid 40617025)
16. Song R, Karon JM, White E, et al. Estimating the distribution of a renewal process from times at which events from an independent process are detected. Biometrics 2006;62:834-46.
17. Karon JM, Song R, Brookmeyer R, et al. Estimating HIV incidence in the United States from HIV/AIDS surveillance data and biomarker HIV test results. Stat Med 2008;27:4617-33.
18. McDougal JS, Parekh BS, Peterson ML, et al. Comparison of HIV type 1 incidence observed during longitudinal follow-up with incidence estimated by cross-sectional analysis using the BED capture enzyme immunoassay. AIDS Res Hum Retrovirol 2006;22:945-52.
19. Brookmeyer R. Should biomarker estimates of HIV incidence be adjusted? AIDS 2009;23:485-91.